In the last trading session, 2.33 million shares of the UroGen Pharma Ltd (NASDAQ:URGN) were traded, and its beta was 0.46. Most recently the company’s share price was $4.19, and it changed around $0.11 or 2.70% from the last close, which brings the market valuation of the company to $193.19M. URGN currently trades at a discount to its 52-week high of $20.70, offering almost -394.03% off that amount. The share price’s 52-week low was $3.42, which indicates that the current value has risen by an impressive 18.38% since then.
UroGen Pharma Ltd stock received a consensus recommendation rating of Buy, based on a mean score of 1.50. If we narrow it down even further, the data shows that 0 out of 9 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 2 recommended URGN as a Hold, whereas 5 deemed it a Buy, and 0 rated it as Underweight.
UroGen Pharma Ltd (NASDAQ:URGN) trade information
Instantly URGN has showed a green trend with a performance of 2.70% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 8.51 on recent trading dayincreased the stock’s daily price by 50.76%. The company’s shares are currently down -60.66% year-to-date, but still down -42.68% over the last five days. On the other hand, UroGen Pharma Ltd (NASDAQ:URGN) is -58.56% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $40, which translates to bulls needing to increase their stock price by 89.53% from its current value. Analyst projections state that URGN is forecast to be at a low of $22 and a high of $60.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 10.39%.
URGN Dividends
UroGen Pharma Ltd’s next quarterly earnings report is expected to be released in June.
ADAGE CAPITAL PARTNERS GP, L.L.C., with 8.9621% or 3.3 million shares worth $55.37 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
iShares Trust-iShares Russell 2000 ETF and Fidelity Salem Street Trust-Fidelity Small Cap Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 998.29 shares worth $4.18 million, making up 2.17% of all outstanding shares. On the other hand, Fidelity Salem Street Trust-Fidelity Small Cap Index Fund held roughly 382.87 shares worth around $1.6 million, which represents about 0.83% of the total shares outstanding.
